Diagnostics
Total Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
1,526
NCT00781339
Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2008
Completion: Mar 31, 2010
NCT01367314
Safety and Efficacy of Topical NVC-422 Gel in Impetigo
Start: Aug 31, 2009
Completion: Dec 31, 2010
NCT01243125
Study to Evaluate NVC-422 for Urinary Catheter Blockage and Encrustation
Start: Nov 30, 2010
Completion: Aug 31, 2013
NCT01532336
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Start: May 31, 2012
Completion: Aug 31, 2014
NCT01670032
Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo
Phase: Phase 2/3
Start: Aug 31, 2012
NCT01877694
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
Start: Jun 30, 2013
Completion: Jan 31, 2015
NCT02130518
Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency
Start: Sep 30, 2014
Completion: Jan 31, 2016
NCT02455895
Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora
Phase: N/A
Start: May 31, 2015
Completion: May 31, 2016
NCT02938078
Ocular Comfort and Inflammation in Lid Hygiene Therapy
Role: Collaborator
Start: Oct 31, 2016
Completion: Aug 24, 2018
NCT03861728
Viral Conjunctivitis Treatment Study
Start: Nov 14, 2018
Completion: Feb 8, 2020
Loading map...